Purpose: Generalized periodic discharges (GPDs) are frequently identified in the EEGs of hospitalized patients but their prognostic significance remains unclear. We retrospectively reviewed clinical data in patients with GPDs to elucidate factors associated with in-hospital mortality. Method: We reviewed data from inpatients at three different hospitals affiliated with our institution in whom GPDs were reported on routine EEGs by fellowship-trained electroencephalographers during the years 2010-2012. Cox regression was used to determine statistical association between in-hospital death and demographics, medical comorbidities, neurological and neuroimaging abnormalities and antiepileptic drug use. Results: We identified 113 patients with GPDs. The mean age was 70.4 years and 70 (61.9%) were women. There were 60 inpatient deaths (53.1%). The variables significantly associated with in-hospital mortality were dementia, poor mental status at the time of the EEG, chronic focal abnormalities on neuroimaging, cardiac arrest and chronic obstructive pulmonary disease (COPD). Conclusion: Dementia, poor mental status during EEG, chronic focal abnormalities on neuroimaging, cardiac arrest and COPD are independently associated with increased in-hospital mortality in patients with GPDs (P < 0.05).
Introduction
Generalized periodic discharges (GPDs) are a distinct type of periodic pattern observed in the electroencephalogram (EEG) of patients with a variety of different conditions such as hypoxicischemic brain injury, intracranial hemorrhage, sepsis, metabolic dysfunction, certain infections such as Creutzfeldt-Jacob disease and subacute sclerosing pan-encephalitis and toxicity from medications such as cefepime, lithium, ifosfamide and baclofen [1] [2] [3] [4] [5] [6] [7] . They are believed to be caused by the disruption of thalamocortical pathways and may have a subcortical origin [3] . GPDs were first described in the 1950s [8] . At present, they are more frequently encountered due to the increasing use of continuous EEG monitoring [9] . GPDs are defined as any synchronous and relatively symmetric repetitive discharges with relatively uniform morphology and duration, with a definable and quantifiable interdischarge interval and recurrence of the wave form at nearly regular intervals [10] . We believe in the near future their recognition will only increase because of modern trends such as the increasing use of continuous EEG monitoring, increasing severity of underlying illnesses being managed in modern ICUs, and an aging population. GPDs are traditionally believed to be indicative of poor prognosis, but only a limited number of small outcome studies are available [2, 3, 9] . While prior studies found GPDs to be associated with poor outcomes [11] [12] [13] , a recent matched case-control study of 200 patients with GPDs using multivariate regression did not find a direct independent association between GPDs and increased mortality when compared to matched controls. However, this study did find that GPDs were strongly associated with non-convulsive status epilepticus (NCSE), which itself was independently associated with increased mortality [9] . To our knowledge, no prospective or dedicated survival analyses describing both the outcome (mortality) and the followup period have been published. Thus, in spite of their increasing recognition, the true prognostic significance of GPDs remains unclear [9] .
In a previous case-control study with 200 patients with GPDs matched to 200 controls [9] , multivariate analysis found that underlying medical illness such as sepsis, cardiac arrest and coma Abbreviations: GPDs, generalized periodic discharges; EEG, electroencephalogram; COPD, chronic obstructive pulmonary disease; CT, computed tomography; MRI, magnetic resonance imaging; EMR, electronic medical record; LFT, liver function test; AED, antiepileptic drugs; PEG, percutaneous endoscopic gastrostomy; NCSE, non-convulsive status epilepticus; ICU, intensive care unit.
were independently associated with increased in-hospital mortality in GPDs patients along with NCSE. That study demonstrates the role of etiology and severity of the primary disease process in determining in-hospital outcomes in patients with GPDs. GPD patients with a history of multiple medical problems had poor outcomes [9] . In our study we performed a survival analysis on 113 patients with GPDs, to assess the hypothesis that certain medical, neurological and neuroimaging abnormalities are associated with increased in-hospital mortality in patients with GPDs.
Methods
We reviewed data from adult inpatients (>18 years old) at three different hospital sites affiliated with our institution (the Moses, Weiler and Wakefield divisions of Montefiore Medical Center, University Hospitals of Albert Einstein College of Medicine, Bronx, New York) in whom GPDs were interpreted by fellowship trained electroencephalographers during a three year period from 2010 to 2012. The EEG reports were reviewed without reexamining the tracings. The study was approved by the Montefiore/Einstein Institutional Review Board. To be included in the study a patient had to have at least one routine EEG with GPDs during that hospital admission.
Routine EEGs were recorded using 21 electrodes placed according to the International 10-20 system [14] . All patients included in this study had received neuroimaging in the form of a computed tomography (CT) scan during the hospitalization in which GPDs were recorded. The patient's electronic medical record was reviewed for age, gender, body weight (kg), the presence of hypertension, diabetes mellitus, coronary artery disease, congestive heart failure, cancer (of any type), liver dysfunction (abnormal LFTs), renal dysfunction (creatinine >1.3), hemodialysis, dementia, COPD, sepsis, any seizures (clinical or electrographic), cardiac arrest (which includes cardiorespiratory arrest), the patient's mental status at the time of the EEG recording, neuroimaging abnormalities, antiepileptic drug (AED) use and the length of hospitalization (days). Mental status at the time of the EEG was classified into three stages of severity (MS-1, MS-2 and MS-3). The description of the patient's mental status as recorded by the primary teams in their progress notes on the day of the EEG study was used to determine the stage. MS-1 included patients who were described as being awake, alert, attentive, oriented or following requests. MS-2 included patients who were described as being confused, disoriented, inattentive, delirious, or stuporous. MS-3 included patients who were described as comatose or unresponsive. Since this classification was retrospective, only three distinct sub-groups were chosen to minimize selection bias. AEDs included continuous or intermittent leviracetam, phenytoin, valproic acid, lacosamide, benzodiazepines, barbiturates, and propofol. The classification of "any seizure" was used for any clinical event suspected to be a seizure by the primary teams or electrographic seizures recorded during the EEG. No separate category was made for status epilepticus. The only EEG features included in the analysis were the presence of GPDs and whether seizures were present.
Any patients with acute ischemic infarction, acute intracranial hemorrhage or acute hypoxic-ischemic injury on neuroimaging were classified as "acute neuroimaging abnormalities" regardless of the presence of coexisting chronic findings. Patients with only findings of old infarcts or mass lesions were classified as "chronic focal neuroimaging abnormalities". Patients without such acute or chronic focal neuroimaging abnormalities but a radiological report of small vessel disease or "white matter changes" were characterized as having leukoaraiosis. We did not quantify the white matter disease or other neuroimaging abnormalities based on severity.
For data analysis commercially available statistical software (SPSS 24.0, Chicago, IL) was used. Cox-regression (multivariate survival analysis) was used to determine statistical associations between in-hospital mortality (outcome) and the clinical predictors as listed above. Length of follow-up was the duration of hospitalization. P values <0.05 were considered as statistically significant. Discharge records were reviewed for a description of the patient's mental status at the time of discharge (similarly classified as MS-1, MS-2, or MS-3), post-discharge site of care, and the presence of either a tracheostomy or a percutaneous endoscopic gastrostomy (PEG). This study did not include postdischarge follow-up.
Results
A total of 113 patients were identified as having GPDs on a routine EEG during their inpatient hospitalization. Their mean age was 70.4 years and 70 (61.9%) were women. Overall there were 60 in-hospital deaths (53.1%) and 53 patients were discharged. The average length of hospitalization was slightly higher in those discharged compared to those who died (mean 40.7 days vs.
days).
A comparative descriptive analysis of patients who were discharged and those who suffered in-hospital deaths is presented in Table 1 . Both groups were comparable with respect to age, gender, body weight, medical comorbidities such as diabetes, hypertension, cancer, liver dysfunction and neurological comorbidities such as dementia and seizures, exhibiting only minor differences as shown in Table 1 . Certain medical conditions such as coronary artery disease, congestive heart failure, renal dysfunction and sepsis were more prevalent in those who suffered in-hospital deaths. The overall number of patients in the sample with cardiac arrest was 29 (25.6%) of whom 21 (72.4%) died in the hospital. The mental status during the EEG of a majority of those who died inhospital was classified as MS-3 (comatose or unresponsive). About 45.0% of patients had either an acute or a chronic focal abnormality on neuroimaging, excluding those with only leukoaraiosis. Acute abnormalities such as acute infarctions, hemorrhage or hypoxicischemic injury were the most common neuroimaging abnormalities, found in 37 patients (32.7%). Chronic focal abnormalities such as an old stroke or mass lesion were present in 14 patients (12.3%). Leukoaraiosis was reported in 21 patients (18.5%). The neuroimaging studies were interpreted as normal in 41 (36.2%) of the patients. Further details of the neuroimaging findings are shown in Table 2 .
The results of survival analysis using Cox regression modeling are shown in Table 1 . We found that a poor mental status (MS-2 and MS-3), dementia, chronic focal abnormalities on neuroimaging, cardiac arrest and COPD were independently associated with increased in-hospital mortality (P < 0.05). Among the 29 patients with cardiac arrest there were 22 deaths (75.8% mortality) and among the 84 without cardiac arrest there were 38 deaths (45.2% mortality). The presence of COPD was not independently associated with cardiac arrest (binary logistic regression model, P < 0.962).
Factors such as seizures, acute neuroimaging abnormalities, age, gender, body weight and medical comorbidities (hypertension, diabetes, coronary artery disease, congestive heart failure, cancer, sepsis, liver or renal dysfunction and hemodialysis use) were not significantly associated with increased in-hospital mortality in our sample of patients with GPDs. Of the 86 patients with GPDs who were on anti-epileptic medications, 48 (55.0%) died. Of the 27 patients not on anti-epileptic medications, 12 died (44.0%). There was no significant association between AED use and in-hospital mortality (P = 0.801). Table 3 describes the mental status and post-discharge site of care of the 53 patients who were discharged. Of these, 33 (61.0%) had a mental status classified as MS-1 at the time of discharge. Thirty-seven of the 53 patients (69.8%) were transferred to a longterm care facility (subacute rehabilitation, nursing home or long term ventilator management facility) for post-discharge care. Only 8 patients (15.0%) were discharged home. Of those discharged, 26 patients (49.0%) had either a tracheostomy or a PEG tube at the time of discharge.
Discussion
In our study of 113 patients with GPDs, poor mental status at the time of the EEG (MS-2 or MS-3), dementia, chronic focal abnormalities on neuroimaging, cardiac arrest and COPD were independently associated with increased in-hospital mortality. The fact that COPD was not independently associated with cardiac arrest reduces the possibility of statistical confounding in the final regression model. The prognosis of patients in our cohort was overall poor with a mortality of 53.0%. Similar mortality rates have been described in other studies of patients with GPDs. In a prior study of 200 patients comparing patients with GPDs and matched controls, the overall mortality in the GPDs group was 41.0%. Two smaller retrospective case series consisting of 25 and 37 patients had documented overall mortalities of 64.0% and 48.7%, respectively [2, 3] .
In our study, there was only a small difference in the mean length of hospitalization between those who died in-hospital (36.4 days) and those who were discharged alive (40.7 days) indicating that patients in whom GPDs are found, including those who ultimately die in-hospital, may have prolonged hospital courses. While most of the patients who were discharged (33/ 53 = 62.2%) were classified as MS-1 at the time of discharge, only 8 patients were discharged home; 37 of these patients were discharged to a long-term care facility and 8 were transferred to hospice care. The small number of patients who were able to be discharged home reflects the residual impairments that were present in most of the patients who survived. This is also shown by the presence of either a tracheostomy or a PEG tube in about half of the discharged patients (49.0%). In our study 20 of the 53 discharged patients (37.8%) had a severely impaired mental status (MS-2 or MS-3) at the time of hospital discharge; this is similar to the study of 200 patients with GPDs in which 40% of patients were found to be severely impaired at discharge [9] . It is possible that some of those discharged to a facility may eventually have returned home but this number is unknown as there was no longterm follow-up of discharged patients in our study.
Consistent with prior studies [9] , GPDs in our sample were found more often in women (61.9%) than in men (38.1%). Prior reports have speculated upon hormonal, genetic or epidemiologic reasons to explain this difference [9] . Of the 60 patients who died in-hospital, 39 (65%) were women, however gender was not independently associated with increased mortality in the final Cox-regression analysis. As shown in Tables 1 and 2 , both groups of patients (i.e. those with in-hospital deaths and those who were discharged alive) were similar with respect to age, body weight, and prevalence of most coexisting medical illnesses. Patients who died in-hospital had higher rates of congestive heart failure, sepsis, and AED use compared to those who were discharged alive but these factors were not statistically significant on multivariable analysis.
Consistent with prior studies [9] , we found cardiac arrest and coma to be independently associated with increased in-hospital mortality, emphasizing the role of underlying disease processes in determining outcomes in these critically ill patients. Additionally, our study showed dementia and COPD to be independently associated with increased in-hospital mortality in patients with GPDs. Dementia is a strong risk factor for in-hospital delirium [15] , which has been independently associated with increased mortality [16] . The association between COPD and increased in-hospital mortality in our cohort is consistent with findings in other studies [17] .
In our study, 11 of 113 patients (9.7%) had seizures at some time during the hospitalization. The prevalence of seizures in our sample is substantially lower than the prior study of 200 patients with GPDs (9.7% vs. 46.0%) [9] . That study used continuous EEG monitoring, which has a greater sensitivity for detecting seizures [9, 18] than routine EEG. The prevalence of seizures in our patients therefore may have been underestimated given that we used only routine EEGs; however, our results may be more applicable to most hospital settings because continuous EEG monitoring is more resourceintensive and its availability is still limited to major academic centers [19] [20] [21] . Prior studies have shown non-convulsive status epilepticus (NCSE) to be significantly associated with GPDs and an independent predictor of mortality in patients with GPDs [9] . Though our study did not specifically categorize NCSE, we did find that poor mental status (MS-2 and MS-3) was independently associated with increased in-hospital mortality. About 76% of patients were given an AED during the study period; however, we did not find any difference in mortality with AED use. We did not analyze for specific medications and the presence of therapeutic responses to these medications. Further questions about the role of AEDs in patients with GPDs remain to be answered.
All 113 patients in our cohort received a CT scan of the head during their hospitalization. Though some did receive magnetic resonance imaging (MRI) scans, we did not consider these separately in our analysis. CT head scans are the preferred initial neuroimaging modality in critically ill patients as the patients may not be able to tolerate MRI studies, which are often longer in duration and logistically more challenging [22] . Cox-regression analysis found chronic focal but not acute neuroimaging abnormalities to be independently associated with increased in-patient mortality but these findings should be interpreted with caution given that the sample size in these subgroups was relatively small. In our analysis we did not find leukoaraiosis to be independently associated with increased mortality. Based on a study of 37 patients with GPDs, 28 of whom had either a CT or MRI scan, with 21 (75.0%) of those showing subcortical lesions, it has been suggested that sub-cortical pathology may be implicated in the generation of GPDs [3] . However, no association of leukoaraiosis with mortality in patients with GPDs has been published.
Our study supports the concept that prognostication in critically ill patients is a complex multifactorial process. Neuroimaging findings, mental status, and underlying neurological and medical conditions should be considered when estimating prognosis in patients with GPDs.
Limitations to the current study include the fact that it is retrospective [23, 24] and that the categorization of the mental status and EEG findings was based on reports from different observers, with the possibility of inter-observer variability in classification. We have tried to reduce this by limiting the classification of mental status to just three easily definable categories. Other EEG features such as background or reactivity were not examined. The sample size of 113 patients is relatively small but to our knowledge this is the second largest case series of GPDs that has been published and the only survival analysis to date [2, 3, 9] . We did not specifically factor palliative care decisions in our survival analysis; thus, withdrawal-of-care decisions may have influenced outcomes. Since this is not a case-control study, it does not specifically address the question of whether the presence of GPDs itself increases in-hospital mortality. The published casecontrol study showed that the presence of GPDs was not associated with an increased mortality [9] .
Conclusion
Our study addresses the question of what coexisting findings are associated with an increased in-hospital mortality in patients with GPDs. We feel our results will be helpful in making prognostic estimates for individual patients and will also form a basis for future statistical models and studies, including those examining the association of other EEG features (such as reactivity and background) with mortality in patients with GPDs. Further prospective studies would be useful to confirm our findings and help to further understand the relationship between these factors and clinical outcomes.
